CD123 POSITIVE PLASMACYTOID DENDRITIC CELLS & CUTANEOUS LUPUS ERYTHEMATOSUS (LE)
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
CD123 POSITIVE PLASMACYTOID DENDRITIC CELLS & CUTANEOUS LUPUS ERYTHEMATOSUS (LE) Ms Nandini Roy (3rd Year Medical Student)1 Dr. Garima Gupta (Specialist Registrar Histopathologist)2 Dr. Rathi Ramakrishnan (Consultant Histopathologist)2 Imperial College School of Medicine1 & Imperial College Healthcare NHS Trust2
INTRODUCTION Cutaneous LE – an autoimmune inflammatory dermatosis affecting skin & subcutaneous tissue Histologically- B & T cells, macrophages in perivascular & adnexal area with interface dermatitis Plasmacytoid dendritic cells (PDCs) are often associated with LE producing interferons and CD123 antigen and are linked to symptoms Identification of PDCs – ? diagnosis value
AIMS AND OBJECTIVES To review cutaneous LE at our centre To assess diagnostic value of CD123 staining PDCs in CLE
MATERIALS AND METHODS CLE diagnosed at Charing Cross Hospital between 2013 & 2017 were reviewed with respect to histology & immunofluorescence (IMF) Immunohistochemistry (IHC) to CD123 was performed & semi-quantitative criteria were developed for assessing staining intensity & patterns of distribution
SEMI-QUANTITATIVE CRITERIA FOR ASSESSMENT Intensity of staining Weak Strong • 1+ • 2+
SEMI-QUANTITATIVE CRITERIA FOR ASSESSMENT Number of clusters 1+ 2+ 3+ •1-2 cluster •3-5 cluster •> 5 clusters involvement involvement
SEMI-QUANTITATIVE CRITERIA FOR ASSESSMENT Overall score generated ≤3 ≥4 • Low expression • High expression
H&E STAINED SECTIONS OF CLE Section showing moderate Section showing moderate perifollicular and perivascular perifollicular lymphoid infiltrate lymphoid infiltrate
RESULTS: POSITIVITY BASED ON STAINING INTENSITY A total of 81 cases of CLE were identified 72/81(88%) cases stained for CD123 45/72 (62%) – 2+ Staining 27/72 (38%) – 1+ Strong(2+) Weak(1+)
RESULTS: PROPORTION OF CELLS 3+ 26/72(36%) – 3+ 2+ 1+ 20/72 (28%) – 2+ 26/72(36%) – 1+ 1+ 2+ 3+ •1-2 cluster • 3-5 cluster •> 5 clusters involvement involvement
CD123 STAINING 1+ distribution with weak staining 2+ distribution with strong staining
3+ distribution with strong staining
RESULTS: OVERALL SCORE/EXPRESSION 28/72 (39%): Low Expression expression 44/72 (61%): High expression Low High
RESULTS CD123 positive PDCs were distributed in perivascular, perifollicular, superficial dermal and deep subcutis Predominantly noted in perivascular 56/72(78%)
RESULTS: CASES WITH IMF DATA IMF available in 34/81 cases (42%). 47/81 (58%) no IMF 12/34 (35%) cases - positive for IgG and C3, 22/34 (65%) – IMF negative Positive 19/22 (86%) with Negative negative IMF were positive for CD123
KEY POINTS High concordance between histologically diagnosed CLE and CD123 staining; Predominantly high overall score (61%) Good diagnostic utility: CD123 staining present even in cases lacking IMF to support histological diagnosis (81% (38/47)) Helps in the distinction of lupus from other neoplastic lymphoid proliferations
REFERENCES 1. Wenzel J, Proelss J, Wiechert A, Zahn S, Bieber T, Tuting T. Cxcr3‐mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus. J. Am. Acad. Dermatol. 2007; 56; 648– 650. 2. Farkas L, Beiske K, Lund‐Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon‐alpha/beta‐ producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 2001; 159; 237–243. 3. Tomasini D, Mentzel T, Hantschke M et al. Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner's lymphocytic infiltrate of the skin and cutaneous lupus erythematosus. J. Cutan. Pathol. 2010; 37; 1132–1139. 4. Marshak‐Rothstein A. Toll‐like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 2006; 6; 823–835. 5. Barrat FJ, Meeker T, Gregorio J et al. Nucleic acids of mammalian origin can act as endogenous ligands for toll‐like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 2005; 202; 1131–1139.
THANK YOU
You can also read